India  

Centre may grant indemnity to COVID vaccine manufacturers Pfizer and Moderna: Sources

Zee News Wednesday, 2 June 2021
Granting indemnity is like giving a concessional request of legal protection from any claims linked to the use of their Covid-19 vaccines in India. India has so far not given an indemnity to any COVID vaccine manufacturer against the costs of compensation for any severe side effects so far.
0
shares
ShareTweetSavePostSend
 
Video Credit: Reuters - Politics - Published
News video: Moderna files for full U.S. approval of COVID-19 vaccine

Moderna files for full U.S. approval of COVID-19 vaccine 01:04

Moderna on Tuesday filed for full U.S. approval of its COVID-19 vaccine, becoming the second drugmaker to do so after Pfizer and its German partner BioNTech sought full clearance for their vaccine last month. This report produced by Freddie Joyner.

You Might Like


Related videos from verified sources

Private hospitals’ vaccine orders only via CoWin from July 1; Govt caps vaccine stock |Oneindia News [Video]

Private hospitals’ vaccine orders only via CoWin from July 1; Govt caps vaccine stock |Oneindia News

Yesterday, the government declared that private hospitals must route Covid vaccine orders via the CoWIN app; Today, the Supreme Court ruled that the Centre must pay compensation to the family of those..

Credit: Oneindia     Duration: 02:36Published
Moderna Says Study Confirms Its COVID Vaccine Protects Well Against Delta Variant [Video]

Moderna Says Study Confirms Its COVID Vaccine Protects Well Against Delta Variant

Moderna says "encouraging" new data backs up the belief that its two-dose COVID vaccine protects against emerging strains of the coronavirus, including the Delta variant.

Credit: WBZ CBS Boston     Duration: 00:21Published
COVID-19 vaccine saturation is uphill battle for health departments, clinics [Video]

COVID-19 vaccine saturation is uphill battle for health departments, clinics

Health departments and clinics around the metro are trying to work through vaccination saturation.

Credit: 41 Action News     Duration: 02:32Published

Related news from verified sources

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources

Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of...
IndiaTimes

Serum Institute of India applies to DCGI to manufacture Sputnik V COVID vaccine, seeks indemnity

Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the SII has also sought...
Zee News